/
DCF Valuation
Base-case fair value
$188.29
Intrinsic $251.06 · 25% MOS
Current price: $284.67
Base-case summary
Our base-case DCF for Bio-Rad Laboratories, Inc. (BIO) projects 10 years of free cash flow growth at 2.0% for years 1–5 and 1.0% for years 6–10, anchored to a default 8% growth assumption, then applies a 2.5% perpetual growth rate and a 8.0% discount rate. Starting from $357M in trailing free cash flow, this produces an intrinsic value of $251.06 per share. A 25% safety margin gives a fair value of $188.29, suggesting the stock is currently 34% overvalued against the $284.67 market price.
See 3 scenarios side by side
Conservative, Base, and Optimistic fair values, plus the sensitivity matrix and FCF history. Free account.
Model inputs
TTM Free Cash Flow
$357M
Cash & equivalents
$1.6B
Total debt
$987M
Shares outstanding
27M